Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 156 entries
View as:

A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain

Phase: N/A Priority: Normal
NCT ID: NCT01606189 Org: User:
Start: 12/31/01 End: 09/30/02 Due: 09/30/03

A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT01812616 Org: User:
Start: 09/30/14 End: 06/30/16 Due: 06/30/17

Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA

Phase: N/A Priority: Normal
NCT ID: NCT02806895 Org: User:
Start: 07/05/16 End: 05/28/19 Due: 05/28/20

A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.

Phase: N/A Priority: Normal
NCT ID: NCT00711646 Org: User:
Start: 06/30/02 End: 03/31/04 Due: 03/31/05

A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00678795 Org: User:
Start: 08/31/02 End: 10/31/05 Due: 10/31/06

A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

Phase: N/A Priority: Normal
NCT ID: NCT00423813 Org: User:
Start: 12/31/06 End: 06/30/09 Due: 06/30/10

Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.

Phase: N/A Priority: Normal
NCT ID: NCT00423605 Org: User:
Start: 12/31/06 End: 01/31/10 Due: 01/31/11

European VOD Registry

Phase: N/A Priority: Normal
NCT ID: NCT03032016 Org: User:
Start: 04/24/15 End: 07/31/19 Due: 07/31/20

Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04745026 Org: User:
Start: 05/31/21 End: 12/21/23 Due: 12/21/24

Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00594945 Org: User:
Start: 12/31/07 End: 06/30/09 Due: 06/30/10

A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults

Phase: N/A Priority: Normal
NCT ID: NCT02224690 Org: User:
Start: 04/28/15 End: 03/18/16 Due: 03/18/17

Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02269579 Org: User:
Start: 04/30/15 End: 06/30/17 Due: 06/30/18

A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)

Phase: N/A Priority: Normal
NCT ID: NCT05122650 Org: User:
Start: 12/06/21 End: 05/30/24 Due: 05/30/25

A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04224272 Org: User:
Start: 06/10/20 End: 06/30/25 Due: 06/30/26

Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients

Phase: N/A Priority: Normal
NCT ID: NCT00086281 Org: User:
Start: 11/30/03 End: 11/30/05 Due: 11/30/06

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03929666 Org: User:
Start: 08/29/19 End: 07/31/25 Due: 07/31/26

Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT04657666 Org: User:
Start: 12/21/20 End: 05/10/22 Due: 05/10/23

Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study

Phase: N/A Priority: Normal
NCT ID: NCT00628498 Org: User:
Start: 12/31/07 End: 09/30/16 Due: 09/30/17

A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension

Phase: N/A Priority: Normal
NCT ID: NCT03533114 Org: User:
Start: 11/27/18 End: 12/18/20 Due: 12/18/21

An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol

Phase: N/A Priority: Normal
NCT ID: NCT02564952 Org: User:
Start: 03/11/16 End: 06/07/17 Due: 06/07/18

Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)

Phase: N/A Priority: Normal
NCT ID: NCT02954887 Org: User:
Start: 05/12/17 End: 06/13/19 Due: 06/13/20

A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01610687 Org: User:
Start: 07/31/01 End: 02/28/05 Due: 02/28/06

A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.

Phase: N/A Priority: Normal
NCT ID: NCT00711880 Org: User:
Start: 05/31/02 End: 03/31/04 Due: 03/31/05

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01643408 Org: User:
Start: 11/30/12 End: 12/31/13 Due: 12/31/14

An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Phase: N/A Priority: Normal
NCT ID: NCT02544750 Org: User:
Start: 08/31/16 End: 06/11/21 Due: 06/11/22